Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Frequency of Arterial Thromboemobolic Events in Patients with Cancer Associated Venous Thromboembolism

Doaa Attia, MD, Xuefei Jia, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-136101

Published: 2020

Journal Articles

Thromboembolism in Patients with Advanced Renal Cell Carcinoma Treated with Immunotherapy

Iris Yeong- Fung Sheng, MD, Shilpa Gupta, MD, Chandana A Reddy, MS, Dana E Angelini, MD, Pauline Funchain, MD, Joanna Roopkumar, MBBS, MPH, Tamara A. Sussman, MD, Joseph Sleiman, MD, Timothy D Gilligan, MD, Moshe C Ornstein, MD MA, Alok A Khorana, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-137140

Published: 2020

Journal Articles

Risk of Recurrent Venous Thromboembolism and Bleeding in Patients with Cancer Associated Thrombosis

Doaa Attia, MD, Xuefei Jia, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-142805

Published: 2020

Journal Articles

Bleeding Outcomes of Gastrointestinal Cancer Patients Treated with Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin

Dana E Angelini, MD, Doaa Attia, MD, Wei Wei, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD

Blood (2020) 136 (Supplement 1): 27.

https://doi.org/10.1182/blood-2020-136757

Published: 2020

Journal Articles

Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of Anticoagulation

Shyam K Poudel, Chandana A Reddy, MS, Deborah Y Park, BS, Mailey L Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS, Jung-Min Song, RN,CNS, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2019) 134 (Supplement_1): 3458.

https://doi.org/10.1182/blood-2019-127581

Published: 2019

Journal Articles

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients

Fahrettin Covut, MD, Ramsha Ahmed, MD, Christy J. Samaras, DO, Faiz Anwer, MD, Alex V. Mejia Garcia, MD, Dana E Angelini, MD, Beth M. Faiman, PhDCNP, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Saveta Mathur, CNP, Kimberly Hamilton, APRN/PA, Nathaniel Rosko, PharmD, Jason Valent, MD, Jack Khouri, MD

Blood (2019) 134 (Supplement_1): 3148.

https://doi.org/10.1182/blood-2019-131400

Published: 2019

Journal Articles

Deaths Due to Thrombotic Versus Bleeding Events within 90 Days of Cancer Associated Thrombosis

Mailey L Wilks, MSN, APRN, NP-C, Shyam K. Poudel, MD, Deborah Y. Park, BS, Xuefei Jia, MS, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barb Tripp, CNS, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Alok A. Khorana, MD, Dana E. Angelini, MD

Blood (2018) 132 (Supplement 1): 3570.

https://doi.org/10.1182/blood-2018-99-117338

Published: 2018

Journal Articles

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Deborah Y. Park, BS, Shyam K. Poudel, MD, Xuefei Jia, MS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS,AOCN, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Dana E. Angelini, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1237.

https://doi.org/10.1182/blood-2018-99-111897

Published: 2018

Journal Articles

Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience

Shyam K. Poudel, MD, Xuefei Jia, MS, Deborah Y. Park, BS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS, AOCN, Jung-Min Song, RN, CNS, Keith R. McCrae, MD, Alok A. Khorana, MD, Dana E. Angelini, MD

Blood (2018) 132 (Supplement 1): 4809.

https://doi.org/10.1182/blood-2018-99-114897

Published: 2018

Journal Articles

Treatment of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience

Shafia Rahman, Dana E. Angelini, MD, Paul Elson, PhD, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barb Tripp, CNS,AOCN, Jung- Min Song, RN,CNS, Keith McCrae, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 4633.

https://doi.org/10.1182/blood.V130.Suppl_1.4633.4633

Published: 2017

Journal Articles

Anticoagulant Prescription Patterns for Cancer Associated Thrombosis: New Insights into the Use of Direct Oral Anticoagulants

Dana E. Angelini, MD, Paul Elson, PhD, Keith McCrae, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 4725.

https://doi.org/10.1182/blood.V130.Suppl_1.4725.4725

Published: 2017

Journal Articles

Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience

Girish Kunapareddy, MD, Benjamin Switzer, DO, MHSA, MS, Madison Conces, MD, Pramod Pinnamaneni, MD, Bhumika J. Patel, MD, Sagar S. Patel, MD, Alicia Redden, Dana E. Angelini, MD, Keith McCrae, MD, Brad Pohlman, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 3361.

https://doi.org/10.1182/blood.V130.Suppl_1.3361.3361

Published: 2017

Journal Articles

A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score

Dana E. Angelini, MD, M. Todd Greene, PhD MPH, Julie N Wietzke, MHSA, MLS, Scott A Flanders, MD, Suman L. Sood, MD MSCE

Blood (2016) 128 (22): 1181.

https://doi.org/10.1182/blood.V128.22.1181.1181

Published: 2016

Journal Articles

E-Selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers

Dana E. Angelini, MD, Sumana Devata, MD, Angela E. Hawley, Susan A. Blackburn, RN, MBA, Satwinder Grewal, Martina V Hemmer, MA, Henry Flanner, MS, William Kramer, PhD, William E Parker, Yu-Ling Li, MS, MD, Daniel Durant Myers, DVM, MPH, James B. Froehlich, MD MPH, John L Magnani, PhD, Helen M. Thackray, MD, Thomas W. Wakefield, MD, Suman L. Sood, MD MSCE

Blood (2016) 128 (22): 3826.

https://doi.org/10.1182/blood.V128.22.3826.3826

Published: 2016

Journal Articles

Biomarkers and Clinical Prediction Rules in the Diagnosis of Suspected Deep Vein Thrombosis: A Comparison of Cancer and Non-Cancer Patients

Jordan K. Schaefer, MD, Dana E. Angelini, MD, Angela Hawley, MS, Susan A. Blackburn, RN, MBA, Elizabeth Lusk, Thomas M. Braun, PhD, Thomas W. Wakefield, MD, Suman L. Sood, MD MSCE

Blood (2016) 128 (22): 3804.

https://doi.org/10.1182/blood.V128.22.3804.3804

Published: 2016

Journal Articles

Defining the Risk: Benefit Ratio of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Cancer Patients

Dana E Angelini, MD, Todd Greene, PhD MPH, Julie N Wietzke, MHSA, MLS, Scott A Flanders, MD, Suman L. Sood, MD

Blood (2015) 126 (23): 627.

https://doi.org/10.1182/blood.V126.23.627.627

Published: 2015

Journal Articles

First in Human Phase 1 Single Dose Escalation Studies of the E-Selectin Antagonist GMI-1271 Show a Favorable Safety, Pharmacokinetic, and Biomarker Profile

Sumana Devata, MD, Suman L. Sood, MD, Martina V Hemmer, MA, Henry Flanner, MS, William Kramer, PhD, Christine Nietubicz, Angela Hawley, Dana E Angelini, MD, Daniel Durant Myers, DVM, MPH, Susan Blackburn, James Froehlich, MD, Thomas W. Wakefield, MD, John L. Magnani, PhD, Helen M. Thackray, MD

Blood (2015) 126 (23): 1004.

https://doi.org/10.1182/blood.V126.23.1004.1004

Published: 2015

Journal Articles

Soluble P-Selectin and Age Adjusted D-Dimer As Predictive Biomarkers of Venous Thrombosis

Dana E Angelini, MD, Cathy Stabler, R.N., Angela E. Hawley, Kenneth E. Guire, M.S., Daniel Durant Myers, DVM,MPH, Susan Blackburn, R.N., Thomas W. Wakefield, MD, Suman L. Sood, MD

Blood (2014) 124 (21): 2863.

https://doi.org/10.1182/blood.V124.21.2863.2863

Published: 2014

NARROW

Frequency of Arterial Thromboemobolic Events in Patients with Cancer Associated Venous Thromboembolism

Thromboembolism in Patients with Advanced Renal Cell Carcinoma Treated with Immunotherapy

Risk of Recurrent Venous Thromboembolism and Bleeding in Patients with Cancer Associated Thrombosis

Bleeding Outcomes of Gastrointestinal Cancer Patients Treated with Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin

Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of Anticoagulation

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients

Deaths Due to Thrombotic Versus Bleeding Events within 90 Days of Cancer Associated Thrombosis

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience

Treatment of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience

Anticoagulant Prescription Patterns for Cancer Associated Thrombosis: New Insights into the Use of Direct Oral Anticoagulants

Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience

A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score

E-Selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers

Biomarkers and Clinical Prediction Rules in the Diagnosis of Suspected Deep Vein Thrombosis: A Comparison of Cancer and Non-Cancer Patients

Defining the Risk: Benefit Ratio of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Cancer Patients

First in Human Phase 1 Single Dose Escalation Studies of the E-Selectin Antagonist GMI-1271 Show a Favorable Safety, Pharmacokinetic, and Biomarker Profile

Soluble P-Selectin and Age Adjusted D-Dimer As Predictive Biomarkers of Venous Thrombosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only